» Articles » PMID: 24505560

Closed Vitrification of Mouse Oocytes Using the CryoLogic Vitrification Method: A Modification That Improves Developmental Competence

Overview
Date 2014 Feb 8
PMID 24505560
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the mouse oocyte vitrification outcomes of the CryoLogic vitrification method (CVM) and the conventional open method using a Cryotop. Two CVM methods (original CVM and modified CVM) were tested.

Methods: Mature oocytes obtained from female BDF-1 mice were vitrified by two-step exposure to equilibrium and vitrification solutions. Three vitrification protocols were tested on three groups: the CVM-kit, modified CVM, and Cryotop groups. After exposure to the two solutions, the oocytes were vitrified. After warming, the oocytes were fertilized in vitro, and the embryo development was assessed. Blastomeres positive for caspase were counted using an in situ assay kit. The spindle morphology and chromosome configurations of warmed vitrified oocytes were also assessed.

Results: The modified CVM and Cryotop groups showed similar developmental capacities, and similar proportions of cells with intact spindles and chromosome configurations. The modified CVM protocol was superior to the original CVM protocol for developmental competence and intact spindle preservation. However, the CVM group showed a relatively higher number of apoptotic cells in blastocysts.

Conclusion: Closed vitrification using the modified CVM protocol may be used as an alternative to the conventional open method, but strategies to decrease apoptosis in the blastomere need to be investigated.

Citing Articles

Comparing the effects of a commercial and a prototype vitrification medium on meiotic spindle morphology and survival rate of mouse oocytes.

Viana I, Vireque A, Navarro P JBRA Assist Reprod. 2022; 26(3):500-507.

PMID: 35261222 PMC: 9355432. DOI: 10.5935/1518-0557.20210117.

References
1.
Parmegiani L, Cognigni G, Filicori M . Ultra-violet sterilization of liquid nitrogen prior to vitrification. Hum Reprod. 2009; 24(11):2969. DOI: 10.1093/humrep/dep329. View

2.
Nagy Z, Chang C, Shapiro D, Bernal D, Kort H, Vajta G . The efficacy and safety of human oocyte vitrification. Semin Reprod Med. 2009; 27(6):450-5. DOI: 10.1055/s-0029-1241054. View

3.
Cobo A, Meseguer M, Remohi J, Pellicer A . Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod. 2010; 25(9):2239-46. DOI: 10.1093/humrep/deq146. View

4.
Huang J, Buckett W, Gilbert L, Tan S, Chian R . Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol. 2007; 105(2):542-4. DOI: 10.1016/j.ygyno.2007.01.036. View

5.
Vanderzwalmen P, Zech N, Prapas Y, Panagiotidis Y, Papatheodorou A, Lejeune B . [Closed carrier device: a reality to vitrify oocytes and embryos in aseptic conditions]. Gynecol Obstet Fertil. 2010; 38(9):541-6. DOI: 10.1016/j.gyobfe.2010.07.011. View